According to a report by Tribune on December 4th, CEO Paul Jefferson Vivas of Apex Pacific Corporation, the manufacturer of the e-cigarette brand Flare, responded to accusations made by Safe Vape Ph. He stated that the accusations of Flare e-cigarettes containing unpermitted formaldehyde components by Safe Vape Ph have damaged Flare's reputation.
"This assertion is completely false and baseless. Flare has adhered strictly to the highest safety and quality standards, undergoing regular third-party laboratory testing to ensure compliance with regulatory requirements. All our products are certified under the Vaporized Nicotine and Non-Nicotine Products Regulation Act (RA 11900)," said Paul Jefferson Vivas, president of Apex Pacific Corporation.
Vivas stated that analysis from an independent laboratory confirmed that Flare products only contain standard levels of formaldehyde. Vivas also refuted the accusations from Safe Vape PH regarding Flare originating from the banned e-cigarette brand Flava by the Department of Trade and Industry (DTI) in the Philippines and being involved in black market distribution channels.
"This is not only untrue but also damaging to our credibility and commitment to lawful operations. We have consistently collaborated with regulatory agencies, including the DTI, to ensure full compliance with legal requirements for the manufacture, distribution, and sale of our products," Vivas said.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
